射血分数降低的心力衰竭患者心房颤动的消融治疗
Ablation for Atrial Fibrillation in Heart Failure with Reduced Ejection Fraction.
作者信息
Liang Jackson J, Callans David J
机构信息
Cardiovascular Division, Electrophysiology Section, Hospital of the University of Pennsylvania Philadelphia, PA, USA.
出版信息
Card Fail Rev. 2018 May;4(1):33-37. doi: 10.15420/cfr.2018:3:1.
Abstract
AF and heart failure with reduced ejection fraction (HFrEF) frequently coexist. Catheter ablation is an increasingly utilised treatment strategy for patients with AF and can be safely performed and is effective in achieving sinus rhythm for patients with HFrEF. Successful ablation may result in improved LV function, clinical heart failure status, quality of life and possibly even mortality. This review summarises the literature analysing efficacy, safety and outcomes of AF ablation for patients with HFrEF.
摘要
心房颤动（AF）与射血分数降低的心力衰竭（HFrEF）常同时存在。导管消融术是治疗AF患者越来越常用的治疗策略，对于HFrEF患者可以安全实施，且在实现窦性心律方面有效。成功的消融可能会改善左心室功能、临床心力衰竭状态、生活质量，甚至可能降低死亡率。本综述总结了分析HFrEF患者AF消融疗效、安全性和结果的文献。
相似文献
1
Ablation for Atrial Fibrillation in Heart Failure with Reduced Ejection Fraction.
Card Fail Rev. 2018 May;4(1):33-37. doi: 10.15420/cfr.2018:3:1.
2
Efficacy, safety, and outcomes of catheter ablation of atrial fibrillation in patients with heart failure with preserved ejection fraction.
J Am Coll Cardiol. 2013 Nov 12;62(20):1857-65. doi: 10.1016/j.jacc.2013.07.020. Epub 2013 Jul 31.
3
Sinus rhythm restores ventricular function in patients with cardiomyopathy and no late gadolinium enhancement on cardiac magnetic resonance imaging who undergo catheter ablation for atrial fibrillation.
Heart Rhythm. 2013 Sep;10(9):1334-9. doi: 10.1016/j.hrthm.2013.06.019. Epub 2013 Jun 27.
4
Catheter ablation of atrial fibrillation in patients with heart failure and preserved ejection fraction.
Heart Rhythm. 2018 May;15(5):651-657. doi: 10.1016/j.hrthm.2017.12.001. Epub 2017 Dec 6.
5
Catheter ablation for atrial fibrillation in heart failure with reduced ejection fraction: a systematic review and meta-analysis of randomized controlled trials.
BMC Cardiovasc Disord. 2019 Jan 15;19(1):18. doi: 10.1186/s12872-019-0998-2.
6
Management of Atrial Fibrillation in Patients with Heart Failure: Time to Implement Ablation Control.
Curr Cardiol Rep. 2019 Feb 21;21(2):10. doi: 10.1007/s11886-019-1093-0.
7
Catheter ablation of atrial fibrillation in heart failure with reduced ejection fraction.
J Cardiovasc Electrophysiol. 2018 Jul;29(7):1049-1058. doi: 10.1111/jce.13497. Epub 2018 Apr 23.
8
Catheter ablation versus conventional treatment of atrial fibrillation in patients with heart failure with reduced ejection fraction: a systematic review and meta-analysis of randomized controlled trials.
J Interv Card Electrophysiol. 2018 Oct;53(1):19-29. doi: 10.1007/s10840-018-0425-0. Epub 2018 Jul 31.
9
Pharmacological management of atrial fibrillation in patients with heart failure with reduced ejection fraction: review of current knowledge and future directions.
Expert Rev Cardiovasc Ther. 2020 Feb;18(2):85-101. doi: 10.1080/14779072.2020.1732210. Epub 2020 Feb 25.
10
Catheter Ablation of Atrial Fibrillation in Patients With Heart Failure.
Am J Cardiol. 2019 Jan 1;123(1):187-195. doi: 10.1016/j.amjcard.2018.09.013. Epub 2018 Sep 26.
引用本文的文献
1
The efficacy and safety of cryoballoon atrial fibrillation ablation in patients with heart failure: A systematic review and meta-analysis.
Indian Pacing Electrophysiol J. 2024 May-Jun;24(3):123-129. doi: 10.1016/j.ipej.2024.01.001. Epub 2024 Jan 12.
2
Long-term efficacy of sodium-glucose cotransporter 2 inhibitor therapy in preventing atrial fibrillation recurrence after catheter ablation in type 2 diabetes mellitus patients.
Heliyon. 2023 Jun 1;9(6):e16835. doi: 10.1016/j.heliyon.2023.e16835. eCollection 2023 Jun.
3
Impact of cavotricuspid isthmus ablation for typical atrial flutter and heart failure in the elderly-results of a retrospective multi-center study.
Front Cardiovasc Med. 2023 Apr 17;10:1109404. doi: 10.3389/fcvm.2023.1109404. eCollection 2023.
4
P-Wave Beat-to-Beat Analysis to Predict Atrial Fibrillation Recurrence after Catheter Ablation.
Diagnostics (Basel). 2022 Mar 28;12(4):830. doi: 10.3390/diagnostics12040830.
5
Concomitant Atrial Fibrillation Procedures During Cardiac Surgery in a UK Center: Reflection of Worldwide Practice?
Front Cardiovasc Med. 2022 Mar 10;9:780893. doi: 10.3389/fcvm.2022.780893. eCollection 2022.
6
Impact of Atrial Tachyarrhythmia Recurrence on the Development of Long-Term Adverse Clinical Events Following Catheter Ablation in Patients With Atrial Fibrillation With Systolic Impairment: A Single-Center Observational Study.
J Am Heart Assoc. 2022 Feb 15;11(4):e023640. doi: 10.1161/JAHA.121.023640. Epub 2022 Feb 3.
7
A Retrospective Cohort Study on Predictors for Rehospitalizations With Recurrence of Atrial Fibrillation Post-Catheter Ablation for Atrial Fibrillation.
Cureus. 2021 Jul 21;13(7):e16536. doi: 10.7759/cureus.16536. eCollection 2021 Jul.
8
Ablation Therapy for Persistent Atrial Fibrillation.
Curr Cardiol Rev. 2022;18(2):e290721195115. doi: 10.2174/1573403X17666210729101752.
9
Extracellular volume fraction by T1 mapping predicts improvement of left ventricular ejection fraction after catheter ablation in patients with non-ischemic dilated cardiomyopathy and atrial fibrillation.
Int J Cardiovasc Imaging. 2021 Aug;37(8):2535-2543. doi: 10.1007/s10554-021-02219-x. Epub 2021 Mar 16.
10
Rhythm Control in Heart Failure Patients with Atrial Fibrillation.
Arrhythm Electrophysiol Rev. 2020 Nov;9(3):161-166. doi: 10.15420/aer.2020.23.
本文引用的文献
1
Catheter Ablation for Atrial Fibrillation with Heart Failure.
N Engl J Med. 2018 Feb 1;378(5):417-427. doi: 10.1056/NEJMoa1707855.
2
Pathophysiology, diagnosis and treatment of tachycardiomyopathy.
Heart. 2017 Oct;103(19):1543-1552. doi: 10.1136/heartjnl-2016-310391. Epub 2017 Aug 30.
3
Catheter Ablation Versus Medical Rate Control in Atrial Fibrillation and Systolic Dysfunction: The CAMERA-MRI Study.
J Am Coll Cardiol. 2017 Oct 17;70(16):1949-1961. doi: 10.1016/j.jacc.2017.08.041. Epub 2017 Aug 27.
4
2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation.
Heart Rhythm. 2017 Oct;14(10):e275-e444. doi: 10.1016/j.hrthm.2017.05.012. Epub 2017 May 12.
5
Heart Rate and Rhythm and the Benefit of Beta-Blockers in Patients With Heart Failure.
J Am Coll Cardiol. 2017 Jun 20;69(24):2885-2896. doi: 10.1016/j.jacc.2017.04.001. Epub 2017 Apr 30.
6
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America.
J Am Coll Cardiol. 2017 Aug 8;70(6):776-803. doi: 10.1016/j.jacc.2017.04.025. Epub 2017 Apr 28.
7
Left atrial volume predicts atrial fibrillation recurrence after radiofrequency ablation: a meta-analysis.
Europace. 2018 Jan 1;20(1):33-42. doi: 10.1093/europace/eux013.
8
Treatment of Patients With Atrial Fibrillation and Heart Failure With Reduced Ejection Fraction.
Circulation. 2017 Apr 18;135(16):1547-1563. doi: 10.1161/CIRCULATIONAHA.116.026054.
9
Mechanistic insights into mitral regurgitation due to atrial fibrillation: "Atrial functional mitral regurgitation".
Trends Cardiovasc Med. 2016 Nov;26(8):681-689. doi: 10.1016/j.tcm.2016.04.012. Epub 2016 May 2.
10
Ablation Versus Amiodarone for Treatment of Persistent Atrial Fibrillation in Patients With Congestive Heart Failure and an Implanted Device: Results From the AATAC Multicenter Randomized Trial.
Circulation. 2016 Apr 26;133(17):1637-44. doi: 10.1161/CIRCULATIONAHA.115.019406. Epub 2016 Mar 30.
Zotero 插件